MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS)
Status:
Terminated
Trial end date:
2017-08-25
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, open label, uncontrolled, non-interventional, single arm
study to measure treatment satisfaction of relapsing remitting MS (RRMS) participants on
Rebif after discontinuing initial first-line treatment.